Detalles de la búsqueda
1.
Predictors for the 5-year risk of serious infections in patients with rheumatoid arthritis treated with anti-tumour necrosis factor therapy: a cohort study in the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry.
Rheumatology (Oxford)
; 52(6): 1052-7, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23365147
2.
The provisional ACR/EULAR definition of remission in RA: a comment on the patient global assessment criterion.
Rheumatology (Oxford)
; 51(6): 1076-80, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22302059
3.
Implementation of a treat-to-target strategy in very early rheumatoid arthritis: results of the Dutch Rheumatoid Arthritis Monitoring remission induction cohort study.
Arthritis Rheum
; 63(10): 2865-72, 2011 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-21647867
4.
Determinants associated with work participation in patients with established rheumatoid arthritis taking tumor necrosis factor inhibitors.
J Rheumatol
; 41(7): 1263-9, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24833758
5.
Effectiveness of a third tumor necrosis factor-α-blocking agent compared with rituximab after failure of 2 TNF-blocking agents in rheumatoid arthritis.
J Rheumatol
; 38(11): 2355-61, 2011 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-21885487
6.
The reason for discontinuation of the first tumor necrosis factor (TNF) blocking agent does not influence the effect of a second TNF blocking agent in patients with rheumatoid arthritis.
J Rheumatol
; 36(10): 2171-7, 2009 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-19723902
Resultados
1 -
6
de 6
1
Próxima >
>>